Suraj Mudichintala

Suraj Mudichintala

Directeur/Membre du Conseil chez Axon Therapies, Inc.

Finance
Consumer Services
Health Technology

Profil

Suraj Mudichintala is a senior associate at APVC in Santa Cruz, CA.
He represents APVC on the Boards of Alpheus Medical, Axon Therapies and Onc.ai.
He was previously an investor at Arboretum Ventures, where he served as a Board observer at Allay Therapeutics, Avation Medical, Francis Medical, Health Scholars, Koya Medical, and RareCyte.
Prior to investing, Suraj was an associate with L.E.K.
Consulting, a global strategy consulting firm.
While at L.E.K., Suraj completed ~20 engagements predominantly for life sciences and private equity clients.
Suraj graduated cum laude with a B.S.
in Finance and Analytics from Boston College.
Suraj previously served on the Michigan Translational Research and Commercialization (MTRAC) Oversight Committee for Medical Devices, where he provided guidance to Michigan higher education researchers on transitioning their early stage products to the private sector for commercialization.

Postes actifs de Suraj Mudichintala

SociétésPosteDébut
Analyste en capital-investissement 01/01/2018
Analyste en capital-investissement 01/06/2022
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Tous les postes actifs de Suraj Mudichintala

Formation de Suraj Mudichintala

Wallace E Carroll School of Management Undergraduate Degree
Boston College Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Suraj Mudichintala

Relations

99

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées5

Finance

Finance

Health Technology

Health Services

Technology Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Suraj Mudichintala